Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By

62 Results

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 09/21/2022 at 5:00 PM (EDT)

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine - Fall 2022 Webinar Series

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine 

    Fall 2022 Webinar Series (6 webinars)

    August 17, 2022 - 5:00 PM ET
         Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
         Jeanmarie Perrone, MD and Lewis Nelson, MD

    August 24, 2022 - 5:00 PM ET
         Case Studies and Q&A - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
         Jeanmarie Perrone, MD and Lewis Nelson, MD

    August 31, 2022 - 12:00 PM ET
         Managing Opioid Complexity in Individuals with Serious Illness
         Jessica Merlin, MD

    September 7, 2022 - 12:00 PM ET
         Case Studies and Q&A: Managing Opioid Complexity in Individuals with Serious Illness
         Jessica Merlin, MD

    September 14, 2022 - 5:00 PM ET
         The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
         Brandon Marshall, PhD

    September 21, 2022 - 5:00 PM ET
         Case Studies and Q&A: The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
         Brandon Marshall, PhD


    Brandon Marshall, PhD

    Brown University School of Public Health

    Dr. Marshall is a professor of epidemiology at the Brown University School of Public Health. He is also founding director of the People, Place & Health Collective at Brown University. Dr. Marshall’s research focuses on substance use epidemiology, with a specific emphasis on harm reduction and overdose prevention. He is passionate about conducting research that improves the health and well-being of people who use drugs.

    Julie Kmiec, DO, FAOAAM (Moderator)

    AOAAM Past President

    Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program and Bridge Clinic, as well as the Narcotic Addiction Treatment Program.
    Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the Immediate Past President of the American Osteopathic Academy of Addiction Medicine.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 09/14/2022 at 5:00 PM (EDT)

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine - Fall 2022 Webinar Series

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine 

    Fall 2022 Webinar Series (6 webinars)

    August 17, 2022 - 5:00 PM ET
         Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
         Jeanmarie Perrone, MD and Lewis Nelson, MD

    August 24, 2022 - 5:00 PM ET
         Case Studies and Q&A - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
         Jeanmarie Perrone, MD and Lewis Nelson, MD

    August 31, 2022 - 12:00 PM ET
         Managing Opioid Complexity in Individuals with Serious Illness
         Jessica Merlin, MD

    September 7, 2022 - 12:00 PM ET
         Case Studies and Q&A: Managing Opioid Complexity in Individuals with Serious Illness
         Jessica Merlin, MD

    September 14, 2022 - 5:00 PM ET
         The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
         Brandon Marshall, PhD

    September 21, 2022 - 5:00 PM ET
         Case Studies and Q&A: The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
         Brandon Marshall, PhD


    Brandon Marshall, PhD

    Brown University School of Public Health

    Dr. Marshall is a professor of epidemiology at the Brown University School of Public Health. He is also founding director of the People, Place & Health Collective at Brown University. Dr. Marshall’s research focuses on substance use epidemiology, with a specific emphasis on harm reduction and overdose prevention. He is passionate about conducting research that improves the health and well-being of people who use drugs.

    Julie Kmiec, DO, FAOAAM (Moderator)

    AOAAM Past President

    Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program and Bridge Clinic, as well as the Narcotic Addiction Treatment Program.
    Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the Immediate Past President of the American Osteopathic Academy of Addiction Medicine.

  • Contains 8 Component(s) Includes Multiple Live Events. The next is on 09/07/2022 at 6:00 PM (EDT) Recorded On: 08/03/2022

    This longitudinal, year-long program (June 2022-March 2023) will offer medical students (MS1-MS4) an opportunity to engage with experts in the field of addiction while working towards the completion of a research project. This opportunity offers interested medical students an opportunity to engage with the clinical and academic aspects of addiction treatment and research. This program will provide the tools to treat patients with Substance Use Disorders in whichever field or specialty you ultimately pursue.

    This longitudinal, year-long program (June 2022-March 2023) will offer medical students (MS1-MS4) an opportunity to engage with experts in the field of addiction while working towards the completion of a research project. 

    This opportunity offers interested medical students an opportunity to engage with the clinical and academic aspects of addiction treatment and research. This program will provide the tools to treat patients with Substance Use Disorders in whichever field or specialty you ultimately pursue.

    Schedule:

    Please watch "The Hungry Heart" prior to 6/1/22.  https://vimeo.com/ondemand/the...

    Dr. Kushner has asked that all mentees view the documentary film "The Hungry Heart" prior to her talk. It's about 90 minutes, and can be rented on Vimeo for $3.99. This should be the only time we ask mentees to spend any money on this program, but if you have issues/questions/concerns, please reach out to Dr. Latronica and we can find an arrangement. She also asked me to mention that some of the language in the documentary (specifically stigmatizing language) likely does not "hold up" in our current environment, but she believes the documentary as a whole is important viewing.

    Time Speaker Meeting 1: Introduction (6/1/22)
    6:00-8:00   Marla Kushner, D.O. "Addiction 101"
    Short Break      
    8:00-9:00   Whole Group Intro Session
         
    Time Speaker Meeting 2: Basics of Harm Reduction (8/3/22)
    6:00-7:00   Mentorship Breakout Groups
    Short Break    
    7:00-8:00 Elizabeth Salisbury-Afshar, M.D. Basics of Harm Reduction
    8:00-8:10   Whole Group Wrap-Up
         
    Time Speaker Meeting 3: Taking a Compassionate Substance Use History (9/7/22)
    6:00-7:00   Mentorship Breakout Groups
    Short Break    
    7:00-8:00 Veronica Ridpath, D.O. Taking a Compassionate Substance Use History
    8:00-8:10   Whole Group Wrap-Up
         
    Time Speaker Meeting 4: Opioid Use Disorder (10/5/22)
    6:00-7:00   Mentorship Breakout Groups
    Short Break    
    7:00-8:00  Katherine Grieco, D.O. Opioid Use Disorder
    8:00-8:10   Whole Group Wrap-Up
         
    Time Speaker Meeting 5: Alcohol Use Disorder (11/2/22)
    6:00-7:00   Mentorship Breakout Groups
    Short Break    
    7:00-8:00  Jon Lepley, D.O. Alcohol Use Disorder
    8:00-8:10   Whole Group Wrap-Up
         
    Time Speaker Meeting 6: Stimulant Use Disorder (12/7/22)
    6:00-7:00   Mentorship Breakout Groups
    Short Break    
    7:00-8:00  James Latronica, D.O. Stimulant Use Disorder
    8:00-8:10   Whole Group Wrap-Up
         
    Time Speaker Meeting 7:  Sedative/Hypnotic Use Disorder(2/1/23)
    6:00-7:00   Mentorship Breakout Groups
    Short Break    
    7:00-8:00  Steve Wyatt, D.O. Sedative/Hypnotic Use Disorder
    8:00-8:10   Whole Group Wrap-Up
         
    Time Speaker Meeting 8: Behavioral Addictions & Project Wrap-Up (3/1/23)
    6:00-7:00   Independent Project Presentations
    Short Break    
    7:00-8:00 Bhavna Bali, M.D. Behavioral Addictions/Malapdaptations
    8:00-8:10   Whole Group Wrap-Up

    Student Mentors:

    • William Bograkos, D.O.
    • Ralph Carbone, D.O.
    • Eric Hargis, D.O.
    • R. Gregory Lande, D.O.
    • David Leszkowitz, D.O.
    • Kristin Martin, D.O.
    • Michael Steelman, D.O.
    • Jan Widerman, D.O.
    • Andrew Williams, D.O.


  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 09/07/2022 at 12:00 PM (EDT)

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine - Fall 2022 Webinar Series

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine 

    Fall 2022 Webinar Series (6 webinars)

    August 17, 2022 - 5:00 PM ET
         Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
         Jeanmarie Perrone, MD and Lewis Nelson, MD

    August 24, 2022 - 5:00 PM ET
         Case Studies and Q&A - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
         Jeanmarie Perrone, MD and Lewis Nelson, MD

    August 31, 2022 - 12:00 PM ET
         Managing Opioid Complexity in Individuals with Serious Illness
         Jessica Merlin, MD

    September 7, 2022 - 12:00 PM ET
         Case Studies and Q&A: Managing Opioid Complexity in Individuals with Serious Illness
         Jessica Merlin, MD

    September 14, 2022 - 5:00 PM ET
         The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
         Brandon Marshall, PhD

    September 21, 2022 - 5:00 PM ET
         Case Studies and Q&A: The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
         Brandon Marshall, PhD


    Jessica Merlin, MD

    University of Pittsburgh

    Dr. Merlin is an Associate Professor in the division of General Internal Medicine and section of Palliative Care and Medical Ethics at the University of Pittsburgh (Pitt) and Director of Pitt’s CHAllenges in Managing and Preventing Pain (CHAMPP) clinical research center. She is a physician and is board certified in internal medicine, infectious disease, palliative care, and addiction medicine. She is also a PhD-trained behavioral scientist and NIH-funded clinician-investigator. Her program of research focuses on the intersection of chronic pain and opioid misuse/use disorder across populations and settings, especially in individuals with serious illnesses like advanced cancer. To that end, she is the MPI of the NIH-funded Tailored Retention and Engagement for Equitable Treatment of Opioid use disorder and Pain (TREETOP) clinical research center, one of four NIH-funded centers focusing on the intersection of pain and opioid use disorder in the US, and the MPI of an R01 to investigate opioid benefits, risks, and decision making in individuals with advanced cancer. Her work in this area is widely published, and she serves as a scientific mentor to many PhD students, post-doctoral fellows, and faculty with similar interests. Clinically, she co-directs the Palliative Recovery Engagement Program, a palliative care clinic embedded in an office-based addiction treatment program, where she sees patients with serious illness, particularly advanced cancer, who also have pain and opioid misuse/use disorder. She has been recognized nationally with a Sojourn Scholars Leadership Award from the Cambia Health Foundation, and with research awards American Academy of Hospice and Palliative Medicine, American Pain Society, and Association for Multidisciplinary Education and Research in Substance use and Addiction. She was recently awarded the 2022 Society of General Internal Medicine Mid-Career Research Mentorship award. 

    Julie Kmiec, DO, FAOAAM (Moderator)

    AOAAM Past President

    Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program and Bridge Clinic, as well as the Narcotic Addiction Treatment Program.
    Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the Immediate Past President of the American Osteopathic Academy of Addiction Medicine.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 08/31/2022 at 12:00 PM (EDT)

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine - Fall 2022 Webinar Series

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine 

    Fall 2022 Webinar Series (6 webinars)

    August 17, 2022 - 5:00 PM ET
         Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
         Jeanmarie Perrone, MD and Lewis Nelson, MD

    August 24, 2022 - 5:00 PM ET
         Case Studies and Q&A - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
         Jeanmarie Perrone, MD and Lewis Nelson, MD

    August 31, 2022 - 12:00 PM ET
         Managing Opioid Complexity in Individuals with Serious Illness
         Jessica Merlin, MD

    September 7, 2022 - 12:00 PM ET
         Case Studies and Q&A: Managing Opioid Complexity in Individuals with Serious Illness
         Jessica Merlin, MD

    September 14, 2022 - 5:00 PM ET
         The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
         Brandon Marshall, PhD

    September 21, 2022 - 5:00 PM ET
         Case Studies and Q&A: The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
         Brandon Marshall, PhD


    Jessica Merlin, MD

    University of Pittsburgh

    Dr. Merlin is an Associate Professor in the division of General Internal Medicine and section of Palliative Care and Medical Ethics at the University of Pittsburgh (Pitt) and Director of Pitt’s CHAllenges in Managing and Preventing Pain (CHAMPP) clinical research center. She is a physician and is board certified in internal medicine, infectious disease, palliative care, and addiction medicine. She is also a PhD-trained behavioral scientist and NIH-funded clinician-investigator. Her program of research focuses on the intersection of chronic pain and opioid misuse/use disorder across populations and settings, especially in individuals with serious illnesses like advanced cancer. To that end, she is the MPI of the NIH-funded Tailored Retention and Engagement for Equitable Treatment of Opioid use disorder and Pain (TREETOP) clinical research center, one of four NIH-funded centers focusing on the intersection of pain and opioid use disorder in the US, and the MPI of an R01 to investigate opioid benefits, risks, and decision making in individuals with advanced cancer. Her work in this area is widely published, and she serves as a scientific mentor to many PhD students, post-doctoral fellows, and faculty with similar interests. Clinically, she co-directs the Palliative Recovery Engagement Program, a palliative care clinic embedded in an office-based addiction treatment program, where she sees patients with serious illness, particularly advanced cancer, who also have pain and opioid misuse/use disorder. She has been recognized nationally with a Sojourn Scholars Leadership Award from the Cambia Health Foundation, and with research awards American Academy of Hospice and Palliative Medicine, American Pain Society, and Association for Multidisciplinary Education and Research in Substance use and Addiction. She was recently awarded the 2022 Society of General Internal Medicine Mid-Career Research Mentorship award. 

    Julie Kmiec, DO, FAOAAM (Moderator)

    AOAAM Past President

    Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program and Bridge Clinic, as well as the Narcotic Addiction Treatment Program.
    Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the Immediate Past President of the American Osteopathic Academy of Addiction Medicine.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 08/24/2022 at 5:00 PM (EDT)

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine - Fall 2022 Webinar Series

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine 

    Fall 2022 Webinar Series (6 webinars)

    August 17, 2022 - 5:00 PM ET
         Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
         Jeanmarie Perrone, MD and Lewis Nelson, MD

    August 24, 2022 - 5:00 PM ET
         Case Studies and Q&A - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
         Jeanmarie Perrone, MD and Lewis Nelson, MD

    August 31, 2022 - 12:00 PM ET
         Managing Opioid Complexity in Individuals with Serious Illness
         Jessica Merlin, MD

    September 7, 2022 - 12:00 PM ET
         Case Studies and Q&A: Managing Opioid Complexity in Individuals with Serious Illness
         Jessica Merlin, MD

    September 14, 2022 - 5:00 PM ET
         The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
         Brandon Marshall, PhD

    September 21, 2022 - 5:00 PM ET
         Case Studies and Q&A: The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
         Brandon Marshall, PhD


    Jeanmarie Perrone, MD

    University of Penn

    Jeanmarie Perrone is a Professor in the Department of Emergency Medicine, and the Director of the Penn Center for Addiction Medicine and Policy.  Dr. Perrone has led multiple initiatives in opioid stewardship and leads a program for the ED treatment of Opioid Use Disorder (OUD).  Dr. Perrone has served on numerous regional and national task forces and advisory committees with the CDC and FDA addressing judicious opioid use and has advocated at the state and national level for harm reduction and ED treatment for OUD.  Dr. Perrone is featured in prominent media including the New York Times, National Public Radio and USA Today and has published in the New England Journal of Medicine and JAMA . She has won numerous awards for education and mentorship of students, residents and fellows and is boarded in emergency medicine, medical toxicology and addiction medicine.

    Lewis Nelson, MD

    Rutgers New Jersey Medical School

    Lewis S. Nelson, MD, MBA is Professor and Chair of the Department of Emergency Medicine, Chief of Service of the University Hospital Emergency Department, and Chief of the Division of Medical Toxicology at Rutgers New Jersey Medical School, all in Newark, NJ. He is also a Senior Consultant to the New Jersey Poison Information & Education System. He is board certified in emergency medicine, medical toxicology, and addiction medicine. Dr. Nelson is an editor of the medical toxicology textbook Goldfrank’s Toxicologic Emergencies and on the editorial boards of several peer-reviewed journals. He is a member of the board of the American Board of Emergency Medicine and several other academic organizations and is Past President of American College of Medical Toxicology. Dr. Nelson serves as a long-standing consultant to CDC, DHS, and FDA and has worked with numerous professional organizations including ACEP and ASAM. Some of his areas of interest include non-opioid pain relief strategies, opioid overdose and management, addiction and withdrawal management, and health policy focused on issues related to medication safety and substance use. 

    Julie Kmiec, DO, FAOAAM (Moderator)

    AOAAM Past President

    Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program and Bridge Clinic, as well as the Narcotic Addiction Treatment Program.
    Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the Immediate Past President of the American Osteopathic Academy of Addiction Medicine.

  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 08/17/2022 at 5:00 PM (EDT)

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine - Fall 2022 Webinar Series

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine - Fall 2022 Webinar Series

    August 17, 2022 - 5:00 PM ET
         Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
         Jeanmarie Perrone, MD and Lewis Nelson, MD

    August 24, 2022 - 5:00 PM ET
         Case Studies and Q&A - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
         Jeanmarie Perrone, MD and Lewis Nelson, MD

    August 31, 2022 - 12:00 PM ET
         Managing Opioid Complexity in Individuals with Serious Illness
         Jessica Merlin, MD

    September 7, 2022 - 12:00 PM ET
         Case Studies and Q&A: Managing Opioid Complexity in Individuals with Serious Illness
         Jessica Merlin, MD

    September 14, 2022 - 5:00 PM ET
         The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
         Brandon Marshall, PhD

    September 21, 2022 - 5:00 PM ET
         Case Studies and Q&A: The State of Harm Reduction in the US: Progress, Barriers, and What's Next.
         Brandon Marshall, PhD


    Jeanmarie Perrone, MD

    University of Penn

    Jeanmarie Perrone is a Professor in the Department of Emergency Medicine, and the Director of the Penn Center for Addiction Medicine and Policy.  Dr. Perrone has led multiple initiatives in opioid stewardship and leads a program for the ED treatment of Opioid Use Disorder (OUD).  Dr. Perrone has served on numerous regional and national task forces and advisory committees with the CDC and FDA addressing judicious opioid use and has advocated at the state and national level for harm reduction and ED treatment for OUD.  Dr. Perrone is featured in prominent media including the New York Times, National Public Radio and USA Today and has published in the New England Journal of Medicine and JAMA . She has won numerous awards for education and mentorship of students, residents and fellows and is boarded in emergency medicine, medical toxicology and addiction medicine.

    Lewis Nelson, MD

    Rutgers New Jersey Medical School

    Lewis S. Nelson, MD, MBA is Professor and Chair of the Department of Emergency Medicine, Chief of Service of the University Hospital Emergency Department, and Chief of the Division of Medical Toxicology at Rutgers New Jersey Medical School, all in Newark, NJ. He is also a Senior Consultant to the New Jersey Poison Information & Education System. He is board certified in emergency medicine, medical toxicology, and addiction medicine. Dr. Nelson is an editor of the medical toxicology textbook Goldfrank’s Toxicologic Emergencies and on the editorial boards of several peer-reviewed journals. He is a member of the board of the American Board of Emergency Medicine and several other academic organizations and is Past President of American College of Medical Toxicology. Dr. Nelson serves as a long-standing consultant to CDC, DHS, and FDA and has worked with numerous professional organizations including ACEP and ASAM. Some of his areas of interest include non-opioid pain relief strategies, opioid overdose and management, addiction and withdrawal management, and health policy focused on issues related to medication safety and substance use. 

    Julie Kmiec, DO, FAOAAM (Moderator)

    AOAAM Past President

    Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program and Bridge Clinic, as well as the Narcotic Addiction Treatment Program.
    Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the Immediate Past President of the American Osteopathic Academy of Addiction Medicine.

  • Contains 18 Component(s), Includes Credits Recorded On: 04/13/2022

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine - Spring 2022 Webinar Series

    Opioid Response Network (ORN) - Hot Topics in Addiction Medicine - Spring 2022 Webinar Series

    April 6, 2022, 2021 – 5 PM ET
         The Impact of Illicit Fentanyl Use on Opioid Use Disorder Treatment
         Andrew Huhn, PhD., M.B.A.

    April 13, 2022 – 5 PM ET
         Case Studies and Q&A: The Impact of Illicit Fentanyl Use on Opioid Use Disorder Treatment
         Andrew Huhn, PhD., M.B.A.

    April 20, 2022 – 5 PM ET
         Drugs, Stigma, and Health
         Robin A. Pollini, PhD MPH

    April 27, 2022 – 5 PM ET
         Case Studies and Q&A: Drugs, Stigma, and Health
         Robin A. Pollini, PhD MPH

    May 4, 2022 – 5 PM ET
         The Fourth Wave: Addressing the Intertwined Fentanyl and Stimulant Overdose Crisis 
         Daniel Ciccarone MD, MPH

    May 11, 2022 – 5 PM ET
         Case Studies and Q&A: The Fourth Wave: Addressing the Intertwined Fentanyl and Stimulant Overdose Crisis
         Steven Shoptaw, MD, PhD


    Andrew Huhn, PhD., M.B.A.

    My research is focused on understanding the human experience of opioid use and opioid use disorder (OUD). The majority of my work has been in human laboratory studies and clinical trials, and I have leveraged my background in psychology, neuroscience, and behavioral pharmacology to identify risk factors for illicit drug relapse and medication strategies to improve OUD treatment outcomes. These studies cover the continuum of care, including supervised opioid withdrawal and sustained recovery using medications for OUD. Topics of interest include sleep disturbance, drug craving, and diurnal measures of stress and mood. In addition, my work in OUD patients has naturally led me to investigate the tradeoffs between the abuse liability and analgesic efficacy of opioid medications, including research on persons with chronic and/or acute pain. My lab employs diverse methodological approaches to better understand opioid use and OUD, including neuroimaging, ecological momentary assessments, wearable technologies, human laboratory studies, and survey research. Taken together, this research is aimed at improving treatment outcomes directly and evaluating and strategizing macro-level changes to improve healthcare for substance use and related disorders.

    Robin Pollini, PhD, MPH

    Dr. Pollini is a substance use and infectious disease epidemiologist whose research focuses on mitigating the adverse health impacts of injection drug use; these include overdose, HIV, viral hepatitis, and serious injection-related bacterial infections like endocarditis. She uses innovative mixed methods study designs to examine how individual- and structural-level factors influence drug-related morbidity and mortality as well as health services access and utilization among people who inject drugs. Dr. Pollini has been Principal Investigator of several grants funded by the National Institute on Drug Abuse (NIDA).

    Daniel Ciccarone, MD, MPH

    Dr. Dan Ciccarone is the Justine Miner Professor in Addiction Medicine in the department of Family and Community Medicine at UCSF. He has been principal or co-investigator on numerous NIH sponsored public health research projects including his current Synthetics in Combination (SYNC) study. He is a recognized international scholar on the medical, public health and public policy dimensions of substance use, risks and consequences. He is Associate Editor for the International Journal of Drug Policy and recently edited an IJDP special issue on the ?triple wave crisis? of opioids, heroin and fentanyl in the US. He consults for numerous private and public entities including the ONDCP, CDC and FDA.

    Steven Shoptaw, PhD

    Steven Shoptaw PhD is Professor in UCLA Departments of Family Medicine and Psychiatry and Biobehavioral Sciences and Professor (Hon) in Psychiatry at the University of Cape Town. Dr. Shoptaw energetically leads research, clinical and policy efforts to bring novel and high impact strategies to deliver culturally competent care and prevention for persons affected by addictions and HIV. He leads two research centers at UCLA on addiction medicine and infectious diseases and is Protocol Co-Chair for an HIV Prevention Trials Network study evaluating a Mobile Health Delivery Unit to Link Persons who Inject Drugs to Integrated Care and Prevention for Addiction, HIV, HCV and Primary Care. Mentoring emerging clinical and research scholars from diverse backgrounds is a strong passion.

    Julie Kmiec, DO, FAOAAM (Moderator)

    AOAAM Past President

    Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program and Bridge Clinic, as well as the Narcotic Addiction Treatment Program.
    Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the Immediate Past President of the American Osteopathic Academy of Addiction Medicine.

  • Contains 3 Component(s), Includes Credits Recorded On: 02/10/2022

    Testimonies from the Trenches Series - Safer Pain Management Practices for Patients with Opioid Use Disorder. The presentation is planned to address how to manage painful conditions in patients on medications for opioid use disorder (MOUD).

    Testimonies from the Trenches: Innovations in Clinical Practice - 

    Safer Pain Management Practices for Patients with Opioid Use Disorder
    The presentation is planned to address how to manage painful conditions in patients on medications for opioid use disorder (MOUD).

    This webinar is free to AOAAM members.
    Non-members at $25. Consider membership!

    Learning objectives:

    1. Describe the neurobiology in the development of addiction
    2. Recognize unhealthy substance use patterns and distinguish between substance misuse and substance use disorder
    3. Analyze risk factors influencing pain management and the development of a substance use disorder
    4. Develop safer opioid prescribing for patients with opioid use disorder and to decrease risk for development of an opioid use disorder
    5. Understand how to use MOUD in treatment of painful conditions

    Outcomes:

    • This activity is designed to improve patient outcomes by increasing learner's knowledge of managing pain for patients on MOUD as well as decreasing the risk for the development of OUD.

    CME: This webinar series has been approved for a maximum 4, AOA Category 1-A CME credits, and AOA designates this for a maximum of 4, AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of the extent of their participation.

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and AOAAM. The AOA is accredited by the ACCME to provide continuing medical education for physicians.

  • Contains 3 Component(s), Includes Credits Recorded On: 01/13/2022

    Testimonies from the Trenches: Buprenorphine in Residential Treatment Settings. This is a 30 minute didactic presentation. This presentation is a description of Buprenorphine as used in an inpatient residential treatment center. It will guide the practitioner through detox, inpatient care and the eventual discharge and post-discharge planning.

    Testimonies from the Trenches: Innovations in Clinical Practice - 

    Buprenorphine in Residential Treatment Settings. 
    This is a 30 minute didactic presentation with (.5 CME). This presentation is a description of Buprenorphine as used in an inpatient residential treatment center. It will guide the practitioner through detox, inpatient care and the eventual discharge and post-discharge planning.

    This webinar is free to AOAAM members.
    Non-members at $25. Consider membership!

    Learning objectives:

    1. Understand the Options of Medicated Assisted Treatment (MAT) for Opioid Use Disorders
    2. To create a framework for guiding a patient to the appropriate MAT
    3. Detox and Induction of Buprenorphine
    4. Post Discharge referrals

    Outcomes:

    • A comfort level on when and how to begin Buprenorphine in detox. (competence, performance)
      The process of making the best decision for an individual patient's MAT (competence, performance and patient outcomes)
      A look at the many factors that are involved in this process (competence)

    CME: This webinar series has been approved for a maximum 4, AOA Category 1-A CME credits, and AOA designates this for a maximum of 4, AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of the extent of their participation.

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and AOAAM. The AOA is accredited by the ACCME to provide continuing medical education for physicians.

    Michael McCormick, DO

    Caron Foundation

    Michael A. McCormick, D.O., is the medical director of the Healthcare Professionals Program, a role he took on in January 2020, after serving as the addiction medicine provider for the program since its inception in 2016. He also leads Caron's Healthcare Professionals Assessment Program and provides daily care to the in-patient healthcare participants. As the physician in charge of the Opioid Treatment Program, he cares for patients who suffer from a particularly deadly disease, helping them with medication-assisted treatment decisions and induction of treatment.

    Employed by Richard J Caron Foundation

    Jon Lepley, DO (Moderator)

    AOAAM President Elect

    Jon Lepley, DO received his medical degree from Lake Erie College of Osteopathic Medicine and he completed his Family Medicine residency training at Heart of Lancaster Regional Medical Center. He is Board Certified by the American Osteopathic Board of Family Physicians, with a Certificate of Added Qualifications in Addiction Medicine. He is a Diplomate of the American Board of Addiction Medicine and he is recognized as a Certified Correctional Health Professional by the National Commission on Correctional Health Care. He has been conferred Fellow status by the American Society of Addiction Medicine.

    Dr. Lepley spent many formative years of practice providing healthcare within the Philadelphia Department of Prisons, wherein he pioneered a program which provides Medication Assisted Treatment to individuals suffering from opioid use disorder. His work in Philadelphia has been recognized by the College of Physicians of Philadelphia Section of Public Health and his program has been presented on a national level, garnering interest from large correctional systems across the country. Dr. Lepley’s clinical interests also include recognition of physician impairment and promotion of physician wellness. In this regard, he volunteers his time to serve on an Advisory Committee for the Pennsylvania Physician Health Program. His current professional role is with Penn Medicine as Medical Director of Addiction Medicine for the Lancaster General Health system.